ShopVision | $4,100,000 | (Sep 19, 2025)
Hydrostor | $55,000,000 | (Sep 19, 2025)
Samara(US) | $34,000,000 | (Sep 19, 2025)
Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
Sevaro | $39,000,000 | (Sep 19, 2025)
Centari | $14,000,000 | (Sep 19, 2025)
Terra Oleo | $3,100,000 | (Sep 19, 2025)
Phia | $8,000,000 | (Sep 19, 2025)
Vibranium Labs | $4,600,000 | (Sep 19, 2025)
Invisible Technologies | $100,000,000 | (Sep 18, 2025)
Stablecore | $20,000,000 | (Sep 18, 2025)
Markup AI | $27,500,000 | (Sep 18, 2025)
Moby | $5,000,000 | (Sep 18, 2025)